Regional and Cellular Mapping of Sortilin Immunoreactivity in Adult Human Brain.

Vps10p dementia neurodegenerative diseases neuronal mapping neuropeptides protein trafficking

Journal

Frontiers in neuroanatomy
ISSN: 1662-5129
Titre abrégé: Front Neuroanat
Pays: Switzerland
ID NLM: 101477943

Informations de publication

Date de publication:
2019
Historique:
received: 23 10 2018
accepted: 21 02 2019
entrez: 28 3 2019
pubmed: 28 3 2019
medline: 28 3 2019
Statut: epublish

Résumé

Sortilin is a member of the vacuolar protein sorting 10 protein (VPS10P) domain receptor family, which carries out signal transduction and protein transport in cells. Sortilin serves as the third, G-protein uncoupled, receptor of neurotensin that can modulate various brain functions. More recent data indicate an involvement of sortilin in mood disorders, dementia and Alzheimer-type neuropathology. However, data regarding the normal pattern of regional and cellular expression of sortilin in the human brain are not available to date. Using postmortem adult human brains free of neuropathology, the current study determined sortilin immunoreactivity (IR) across the entire brain. Sortilin IR was broadly present in the cerebrum and subcortical structures, localizing to neurons in the somatodendritic compartment, but not to glial cells. In the cerebrum, sortilin IR exhibited differential regional and laminar patterns, with pyramidal, multipolar and polymorphic neurons in cortical layers II-VI, hippocampal formation and amygdaloid complex more distinctly labeled relative to GABAergic interneurons. In the striatum and thalamus, numerous small-to-medium sized neurons showed light IR, with a small group of large sized neurons heavily labeled. In the midbrain and brainstem, sortilin IR was distinct in neurons at the relay centers of descending and ascending neuroanatomical pathways. Dopaminergic neurons in the substantia nigra, cholinergic neurons in the basal nuclei of Meynert and noradrenergic neurons in the locus coeruleus co-expressed strong sortilin IR in double immunofluorescence. In comparison, sortilin IR was weak in the olfactory bulb and cerebellar cortex, with the mitral and Purkinje cells barely visualized. A quantitative analysis was carried out in the lateral, basolateral, and basomedial nuclei of the amygdaloid complex, as well as cortical layers II-VI, which established a positive correlation between the somal size and the intensity of sortilin IR among labeled neurons. Together, the present study demonstrates a predominantly neuronal expression of sortilin in the human brain with substantial regional and cell-type variability. The enriched expression of sortilin in pyramidal, dopaminergic, noradrenergic and cholinergic neurons suggests that this protein may be particularly required for signal transduction, protein trafficking and metabolic homeostasis in populations of relatively large-sized projective neurons.

Identifiants

pubmed: 30914927
doi: 10.3389/fnana.2019.00031
pmc: PMC6422922
doi:

Types de publication

Journal Article

Langues

eng

Pagination

31

Références

Eur J Neurosci. 1999 Mar;11(3):967-74
pubmed: 10103090
Eur J Pharmacol. 2000 Feb 25;390(1-2):107-11
pubmed: 10708713
Neuropharmacology. 2000 Jun 8;39(8):1430-42
pubmed: 10818259
Neuropharmacology. 2001 Jun;40(8):1073-83
pubmed: 11406199
Biol Psychiatry. 2002 May 15;51(10):795-800
pubmed: 12007453
Bioorg Med Chem. 2002 Dec;10(12):3849-58
pubmed: 12413837
Curr Opin Drug Discov Devel. 2002 Sep;5(5):764-76
pubmed: 12630297
J Comp Neurol. 2003 Jul 7;461(4):483-505
pubmed: 12746864
J Comp Neurol. 2003 Jul 7;461(4):520-38
pubmed: 12746866
Neurotox Res. 2002 Aug-Sep;4(5-6):453-468
pubmed: 12754159
J Histochem Cytochem. 2003 Jun;51(6):841-52
pubmed: 12754295
Neuroscience. 2003;119(2):547-55
pubmed: 12770567
Psychopharmacology (Berl). 1992;109(3):369-72
pubmed: 1365637
Nature. 2004 Feb 26;427(6977):843-8
pubmed: 14985763
Neuroscience. 2005;130(2):309-15
pubmed: 15664687
J Neurosci. 2005 Mar 9;25(10):2518-21
pubmed: 15758160
J Neurosci. 2005 Jun 29;25(26):6156-66
pubmed: 15987945
CNS Neurol Disord Drug Targets. 2006 Apr;5(2):205-18
pubmed: 16611093
Neuroscience. 2006 Sep 15;141(4):1871-8
pubmed: 16814931
Brain Res. 1990 Dec 24;537(1-2):298-302
pubmed: 1707731
Brain Res. 2007 Dec 5;1183:32-42
pubmed: 17964555
Prog Brain Res. 1991;88:241-8
pubmed: 1813923
Eur J Neurosci. 2008 Apr;27(8):2103-14
pubmed: 18412630
Nat Struct Mol Biol. 2009 Jan;16(1):96-8
pubmed: 19122660
Histol Histopathol. 2009 Apr;24(4):481-92
pubmed: 19224451
Neuroscience. 1990;39(2):351-60
pubmed: 1965015
Mini Rev Med Chem. 2009 Oct;9(12):1429-38
pubmed: 19929816
Neurosci Lett. 2010 Mar 8;471(3):129-33
pubmed: 20085800
Am J Hum Genet. 2010 Dec 10;87(6):890-7
pubmed: 21087763
Neuron. 2010 Nov 18;68(4):654-67
pubmed: 21092856
J Biol Chem. 2011 Apr 8;286(14):12602-16
pubmed: 21245145
J Pharmacol Exp Ther. 1990 Feb;252(2):817-25
pubmed: 2138224
J Neurosci Res. 2011 Oct;89(10):1618-26
pubmed: 21656844
Biochem Pharmacol. 2012 Mar 1;83(5):559-66
pubmed: 22051078
Trends Neurosci. 2012 Apr;35(4):261-70
pubmed: 22341525
Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21510-5
pubmed: 23236149
J Neurosci. 2013 Jan 2;33(1):64-71
pubmed: 23283322
J Neurosci. 2013 Jan 2;33(1):358-70
pubmed: 23283348
Biochem Biophys Res Commun. 2013 Feb 15;431(3):579-85
pubmed: 23313508
Biochem Biophys Res Commun. 2013 Mar 29;433(1):90-5
pubmed: 23485461
Eur J Pharmacol. 2013 Sep 15;716(1-3):54-60
pubmed: 23500196
PLoS One. 2013 May 21;8(5):e63049
pubmed: 23704887
Bioorg Med Chem. 2013 Jul 15;21(14):4378-87
pubmed: 23721919
Rev Port Cardiol. 2013 Oct;32(10):793-9
pubmed: 23910371
Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):451-60
pubmed: 24531479
J Neurosci. 2014 May 14;34(20):7027-42
pubmed: 24828655
Protein Sci. 2014 Sep;23(9):1291-300
pubmed: 24985322
Curr Pharm Des. 2015;21(7):840-8
pubmed: 25345606
Behav Sci (Basel). 2014 Jun 13;4(2):125-53
pubmed: 25379273
Curr Atheroscler Rep. 2015 Apr;17(4):496
pubmed: 25702058
Lancet Neurol. 2015 Feb;14(2):136
pubmed: 25772887
Curr Pharm Des. 2015;21(26):3807-12
pubmed: 26044977
Front Neuroanat. 2015 Jun 01;9:64
pubmed: 26082686
J Cell Biol. 2015 Sep 14;210(6):991-1002
pubmed: 26370502
Transl Psychiatry. 2015 Nov 10;5:e677
pubmed: 26556286
Dev Neurobiol. 2016 Sep;76(9):939-55
pubmed: 26585436
Proc Natl Acad Sci U S A. 1977 May;74(5):1846-50
pubmed: 266706
Neuropsychopharmacology. 2016 Aug;41(9):2206-14
pubmed: 26868058
J Alzheimers Dis. 2016 Jul 1;53(4):1353-63
pubmed: 27392867
J Affect Disord. 2017 Jan 15;208:443-447
pubmed: 27838145
J Comp Neurol. 2017 Feb 1;525(2):407
pubmed: 27917481
Neurosci Lett. 1987 Dec 16;83(1-2):47-52
pubmed: 2831477
Clin Exp Pharmacol Physiol. 2017 Aug;44(8):841-846
pubmed: 28556374
Front Neuroanat. 2017 Jun 07;11:45
pubmed: 28638323
Exp Neurol. 2018 Jan;299(Pt A):75-85
pubmed: 29056359
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E11029-E11036
pubmed: 29203673
PLoS Biol. 2018 Jan 30;16(1):e2004411
pubmed: 29381698
J Biol Chem. 2018 Mar 23;293(12):4532-4544
pubmed: 29382723
J Comp Neurol. 2018 Jun 1;526(8):1267-1286
pubmed: 29405286
Circ Res. 2018 Mar 2;122(5):652-654
pubmed: 29496794
Neurobiol Aging. 2018 Jun;66:181.e3-181.e10
pubmed: 29555433
Neurobiol Aging. 2018 Jul;67:10-20
pubmed: 29609077
Biochem Cell Biol. 2018 Oct;96(5):491-497
pubmed: 29687731
Alzheimers Res Ther. 2018 Apr 24;10(1):40
pubmed: 29690919
Acta Neuropathol. 2018 Jul;136(1):1-17
pubmed: 29744576
Methods Mol Biol. 2018;1806:269-288
pubmed: 29956282
FEBS Lett. 2018 Aug;592(15):2647-2657
pubmed: 29972886
Front Pharmacol. 2018 Aug 06;9:863
pubmed: 30127743
Proc Natl Acad Sci U S A. 1986 Aug;83(16):6203-7
pubmed: 3016745
Neurosci Lett. 1987 May 6;76(2):145-50
pubmed: 3035436
Brain Res. 1987 Jun 2;412(2):244-53
pubmed: 3038264
Neurosci Bull. 2019 Apr;35(2):270-276
pubmed: 30411305
Neuroscience. 1987 Aug;22(2):525-36
pubmed: 3313097
Proc Natl Acad Sci U S A. 1977 Sep;74(9):4059-63
pubmed: 333458
Histochemistry. 1977 Jul 18;53(1):35-41
pubmed: 409699
J Biol Chem. 1973 Oct 10;248(19):6854-61
pubmed: 4745447
J Histochem Cytochem. 1979 Oct;27(10):1398-400
pubmed: 512327
Brain Res. 1984 Aug 6;308(1):186-90
pubmed: 6089953
Nature. 1981 Dec 10;294(5841):587-9
pubmed: 6273751
Biochem Biophys Res Commun. 1984 Apr 16;120(1):206-13
pubmed: 6324791
J Neurochem. 1982 Jun;38(6):1777-80
pubmed: 7077336
J Comp Neurol. 1994 Mar 15;341(3):407-19
pubmed: 8195468
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65-9
pubmed: 8380498
FEBS Lett. 1996 May 20;386(2-3):91-4
pubmed: 8647296
Cereb Cortex. 1996 May-Jun;6(3):524-9
pubmed: 8670678
Cereb Cortex. 1996 Jul-Aug;6(4):620-30
pubmed: 8670687
Brain. 1996 Jun;119 ( Pt 3):823-30
pubmed: 8673494
J Comp Neurol. 1996 Sep 09;373(1):76-89
pubmed: 8876464
J Biol Chem. 1997 Feb 7;272(6):3599-605
pubmed: 9013611
Neuropharmacology. 1977 Sep;16(9):625-9
pubmed: 917267
Eur J Pharmacol. 1998 Feb 5;343(1):67-77
pubmed: 9551716
J Neural Transm (Vienna). 1998;105(4-5):507-16
pubmed: 9720978
Pharmacol Ther. 1998 Aug;79(2):89-104
pubmed: 9749878
J Biol Chem. 1998 Oct 9;273(41):26273-6
pubmed: 9756851
J Comp Neurol. 1998 Dec 28;402(4):475-500
pubmed: 9862322

Auteurs

Shu-Yin Xu (SY)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.

Qi-Lei Zhang (QL)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.

Qi Zhang (Q)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.

Lily Wan (L)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.

Juan Jiang (J)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.

Tian Tu (T)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.

Jim Manavis (J)

SA Pathology, Schools of Medicine and Veterinary Science, Hanson Institute Centre for Neurological Diseases, The University of Adelaide, Adelaide, SA, Australia.

Aihua Pan (A)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.
Center for Morphological Sciences, School of Basic Medicine, Central South University, Changsha, China.

Yan Cai (Y)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.
Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, China.

Xiao-Xin Yan (XX)

Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China.
Key Laboratory of Hunan Province in Neurodegenerative Disorders, Xiangya Hospital, Central South University, Changsha, China.

Classifications MeSH